0 Items
Select Page

Flavivirus Receptors

The Native Antigen Company manufacturers highly purified virus-host cell receptors using state-of-the-art expression and purification techniques. On request we can also undertake custom preparation of recombinant and native proteins for a broad range of disease states.

Flavivirus Receptors Background

Viruses are obligate intracellular pathogens and consequently need to gain entry into a host cell for completion of their life cycle. In order to enter to a cell, viruses attach to specific receptor molecules on the cell surface; molecules which also play an important role in normal cell function. Different viruses have evolved complex mechanisms to bind to these membrane-associated proteins and gain access to the cell interior.

Flaviviridae are small enveloped positive strand RNA viruses of an approximate diameter of 50 nm, which replicate in the cytoplasm of their respective host cell. The flavivirus family includes many mosquito-borne viruses, including Dengue virus (DENV), Yellow fever virus (YFV), West-Nile virus (WNV), Japanese encephalitis virus (JEV), Zika virus (ZIKV) and tick-borne encephalitis virus (TBEV), as well as blood-borne hepatitis C virus (HCV) (Knipe & Howley, 2013).

Flaviviruses enter cells by interaction of their E glycoprotein with cell surface receptors; these allow the virions to absorb onto the cell surface and enter the cells through receptor-mediated endocytosis. Secondary receptors may also be utilised to puncture the membrane or for fusion with the host cell. A specific receptor for internalization of flaviviruses into host cells has not yet been identified. It is believed that flaviviruses make initial contact with the host cell by binding to glycosaminoglycans (GAGs), such as heparan-sulfate proteoglycans or syndecans. However, the identity of the cellular receptors that mediate flavivirus entry and infection is still poorly known. A large number of attachment molecules such as DC-SIGN have been described as flavivirus candidate receptors in different cell types, but their precise role in virus endocytosis remains obscure. The best-characterized candidate proteins to date are C-type lectin receptors (CLEC5A) and the phosphatidylserine receptors, T-cell immunoglobulin and mucin domain (TIM) and TYRO3, AXL and MER (TAM) (Perera-Lecoin, et al., 2014; Laureti, et al., 2018).

Therefore, the E protein and its putative receptor and attachment molecules make promising targets for the design of antivirals and vaccine development.

References

Flavivirus Receptors

We offer a range of flavivirus receptors comprising highly purified recombinant proteins known to bind to a broad spectrum of viruses.

 

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Diagnosing HIV in resource-limited settings

In this blog, we discuss the need for improved point-of-care (PoC) diagnostics for HIV and present the virus's cellular mechanism to illustrate our new range of HIV antigens and antibodies. HIV in the developed world On June 5th 1981 in Los Angeles, California, 5...

Our Product Pipeline

If you’ve been following us on social media recently, you might have noticed that we’ve been releasing a lot of new antigens and antibodies. In this blog, we explain how we use the WHO R&D Blueprint to guide our product development and present some highlights from...

From Outbreak to Epidemic: A Short History of The Ebola Virus

In the first of a two-part series, we discuss the history of the Ebola virus up to the ongoing outbreak in the Democratic Republic of Congo, and why this disease has been so challenging to fight. The 2014/15 epidemic In the summer of 2014, the world watched as the...

ELISA Formats for Infectious Disease Diagnostics

The field of diagnostics is rapidly developing, yet ELISA and PCR methods remain the most commonly used techniques in the diagnosis of bacterial and viral infections. In this blog, we discuss the advantages of using serological methods over molecular, PCR-based...

The world’s most extensive range of NS1-specific antibodies for flavivirus research

The Native Antigen Company first gained prominence in 2016, when it developed highly pure Zika virus NS1 protein during the 2015/2016 epidemic. Since then, the company has developed an extensive range of highly specific antigens, antibodies and immunoassays for...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

12 + 13 =

Live Customer Feedback

Join our mailing list

* indicates required